Julia Lainster

A fundamental shift is underway in the landscape of oncology, where the promise of precision medicine is rapidly becoming a clinical reality, moving treatment from generalized protocols to strategies tailored to an individual’s unique genetic makeup. A pivotal research effort has culminated in the

Sophisticated nanodelivery systems that respond to multiple biological cues are rapidly redefining the landscape of targeted therapeutics, offering a highly precise method for overcoming the formidable barriers presented by diseases like metastatic cancer. This review explores the evolution of

With us today is Ivan Kairatov, a biopharma expert with deep experience in research and development, to discuss the evolving story of Sarepta’s gene therapy, Elevidys. We’ll explore how new long-term data is reshaping the clinical conversation around the therapy’s effectiveness, the commercial

The silent progression of prediabetes into a life-altering diagnosis of type 2 diabetes may soon be intercepted by a groundbreaking blood test powered by artificial intelligence. Recent research has unveiled a novel method that combines AI with molecular medicine to analyze blood for specific

The intricate web of modern healthcare technology, designed to streamline patient care, has once again demonstrated its potential vulnerability after a significant data breach at a third-party vendor exposed the sensitive records of patients from Jupiter Medical Center. The incident, which did not

A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue

As a leading expert in biopharma and technological innovation, Ivan Kairatov has dedicated his career to the intersection of health and R&D. Today, we delve into a groundbreaking study where artificial intelligence analyzed WhatsApp voice messages to detect major depressive disorder, a condition

In a significant move that could reshape the landscape of cardiovascular medicine for millions of Americans, a comprehensive bipartisan appropriations bill is advancing through Congress, carrying with it major implications for how patients access care and how the nation invests in medical research.

We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and research is pushing the boundaries of what’s possible in patient care. We'll be exploring a groundbreaking AI-powered wearable that translates silent throat movements into fluent speech for

A groundbreaking therapeutic strategy that combines a systemic targeted drug with a standard locoregional treatment is showing unprecedented promise in preventing the recurrence of hepatocellular carcinoma (HCC) among high-risk patients who have undergone surgery. This comprehensive analysis of a